Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins

Journal of Virology

Volumn 88, Issue 9, 2014, Pages 4828-4838

  Yang, Hua ^a   Chang, Jessie C ^a   Guo, Zhu ^a   Carney, Paul J ^a   Shore, David A ^a   Donis, Ruben O ^a   Cox, Nancy J ^a   Villanueva, Julie M ^a   Klimov, Alexander I ^a   Stevens, James ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; MONOMER; POLYMER; RECOMBINANT PROTEIN; TRIMER; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; INFLUENZA VIRUS A H1N1; LIGHT SCATTERING; MOLECULAR INTERACTION; MOLECULAR STABILITY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN MICROARRAY; VIRUS EXPRESSION; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS STRAIN; X RAY CRYSTALLOGRAPHY;

CHROMATOGRAPHY, GEL; CRYSTALLOGRAPHY, X-RAY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; SEQUENCE ANALYSIS, DNA; TEMPERATURE;

EID: 84897557489     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02278-13     Document Type: Article

References (38)

1. World Health Organization. 2009. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/print.html.
2. Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG, Sachedina N, White PJ, Hawkins C, Evans B, Waight PA, Ellis J, Bermingham A, Donaldson LJ, Catchpole M. 2011. Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol. Infect. 139:1560-1569. http://dx.doi.org/10.1017/S0950268810002657.
3. Centers for Disease Control and Prevention. 2010. Update: influenza activity-United States, 2009-10 season. MMWR Morb. Mortal. Wkly. Rep. 59:901-908.
4. World Health Organization. 2013. Recommended composition of influenza virus vaccines for use in the 2014 southern hemisphere influenza season. Wkly. Epidemiol. Rec. 88:437-448. http://www.who.int/wer/2013/wer8841/en/.
5. Jimenez-Alberto A, Alvarado-Facundo E, Ribas-Aparicio RM, Castelan-Vega JA. 2013. Analysis of adaptation mutants in the hemagglutinin of the influenza A(H1N1)pdm09 virus. PLoS One 8:e70005. http://dx.doi.org/10.1371/journal.pone.0070005.
6. Yang H, Carney P, Stevens J. 2010. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. Influenza 2:RRN1152. http://dx.doi.org/10.1371/currents.RRN1152.
7. Yang H, Carney PJ, Donis RO, Stevens J. 2012. Structure and receptor complexes of the hemagglutinin from a highly pathogenicH7N7influenza virus. J. Virol. 86:8645-8652. http://dx.doi.org/10.1128/JVI.00281-12.
8. Yang H, Chen LM, Carney PJ, Donis RO, Stevens J. 2010. Structures of receptor complexes of a north American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog. 6:e1001081. http://dx.doi.org/10.1371/journal.ppat.1001081.
9. Frank S, Kammerer RA, Mechling D, Schulthess T, Landwehr R, Bann J, Gou Y, Lustig A, Bächinger HP, Engel J. 2001. Stabilization of short collagen-like triple helices by protein engineering. J. Mol. Biol. 308:1081-1089. http://dx.doi.org/10.1006/jmbi.2001.4644.
10. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. 2004. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866-1870. http://dx.doi.org/10.1126/science.1093373.
11. Otwinowski A, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326. http://dx.doi.org/10.1016/S0076-6879(97)76066-X.
12. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ. 2005. Likeli-hood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61:458-464. http://dx.doi.org/10.1107/S0907444905001617.
13. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132. http://dx.doi.org/10.1107/S0907444904019158.
14. Winn MD, Isupov MN, Murshudov GN. 2001. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 57:122-133. http://dx.doi.org/10.1107/S0907444900014736.
15. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB, III, Snoeyink J, Richardson JS, Richardson DC. 2007. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35:W375-W383. http://dx.doi.org/10.1093/nar/gkm216.
16. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410. http://dx.doi.org/10.1126/science.1124513.
17. Feshchenko E, Rhodes DG, Felberbaum R, McPherson C, Rininger JA, Post P, Cox MM. 2012. Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights intoH1N1antigen stability.BMCBiotechnol. 12:77. http://dx.doi.org/10.1186/1472-6750-12-77.
18. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. 2007. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J. 4:42. http://dx.doi.org/10.1186/1743-422X-4-42.
19. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26:107-113. http://dx.doi.org/10.1038/nbt1375.
20. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427. http://dx.doi.org/10.1016/0092-8674(82)90135-0.
21. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. 1999. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. U. S. A. 96:1651-1656. http://dx.doi.org/10.1073/pnas.96.4.1651.
22. Brownlee GG, Fodor E. 2001. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:1871-1876. http://dx.doi.org/10.1098/rstb.2001.1001.
23. Huang JW, Lin WF, Yang JM. 2012. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays. Vaccine 30:6327-6337. http://dx.doi.org/10.1016/j.vaccine.2012.07.079.
24. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372:774-797. http://dx.doi.org/10.1016/j.jmb.2007.05.022.
25. Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. 2010. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Vaccine 28:2442-2449. http://dx.doi.org/10.1016/j.vaccine.2009.12.079.
26. US Food and Drug Administration. 2010. Biologics recalls. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/Recalls/default.htm.
27. Health Canada. 9 April 2010. New expiry date for unused adjuvanted H1N1 vaccine (Arepanrix). http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/13496a-eng.php.
28. Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, Guilfoyle K, Roseby S, Newman R, Collin R, Wallis C, Engelhardt OG, Wood JM, Le J, Manojkumar R, Pokorny BA, Silverman J, Devis R, Bucher D, Verity E, Agius C, Camuglia S, Ong C, Rockman S, Curtis A, Schoofs P, Zoueva O, Xie H, Li X, Lin Z, Ye Z, Chen LM, O'Neill E, Balish A, Lipatov AS, Guo Z, Isakova I, Davis CT, Rivailler P, Gustin KM, Belser JA, Maines TR, Tumpey TM, Xu X, Katz JM, Klimov A, Cox NJ, Donis RO. 2011. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 29:1836-1843. http://dx.doi.org/10.1016/j.vaccine.2010.12.044.
29. Farnsworth A, Cyr TD, Li C, Wang J, Li X. 2011. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain. Vaccine 29:1529-1533. http://dx.doi.org/10.1016/j.vaccine.2010.12.120.
30. Nicolson C, Harvey R, Johnson R, Guilfoyle K, Engelhardt OG, Robertson JS. 2012. An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine 30:745-751. http://dx.doi.org/10.1016/j.vaccine.2011.11.081.
31. Zhang W, Shi Y, Lu X, Shu Y, Qi J, Gao GF. 2013. An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science 340:1463-1467. http://dx.doi.org/10.1126/science.1236787.
32. Maurer-Stroh S, Lee RT, Eisenhaber F, Cui L, Phuah SP, Lin RT. 2010. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr. Influenza 2:RRN1162. http://dx.doi.org/10.1371/currents.RRN1162.
33. Galiano M, Agapow PM, Thompson C, Platt S, Underwood A, Ellis J, Myers R, Green J, Zambon M. 2011. Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS One 6:e23779. http://dx.doi.org/10.1371/journal.pone.0023779.
34. Kao CL, Chan TC, Tsai CH, Chu KY, Chuang SF, Lee CC, Li ZR, Wu KW, Chang LY, Shen YH, Huang LM, Lee PI, Yang C, Compans R, Rouse BT, King CC. 2012. Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One 7:e31162. http://dx.doi.org/10.1371/journal.pone.0031162.
35. Cotter CR, Jin H, Chen Z. 2014. A single amino acid in the stalk region of the H1N1pdm influenza virusHAprotein affects viral fusion, stability and infectivity. PLoS Pathog. 10:e1003831. http://dx.doi.org/10.1371/journal.ppat.1003831.
36. Rachakonda PS, Veit M, Korte T, Ludwig K, Bottcher C, Huang Q, Schmidt MF, Herrmann A. 2007. The relevance of salt bridges for the stability of the influenza virus hemagglutinin. FASEB J. 21:995-1002. http://dx.doi.org/10.1096/fj.06-7052hyp.
37. World Health Organization. 2012. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Wkly. Epidemiol. Rec. 87:389-400. http://www.who.int/wer/201 2/en.
38. Delano WL. 2002. The Pymol molecular graphics system. http://www.pymol.org.